Définition et prise en charge de l’échec d’une première injection de toxine botulique Botox® 200 U pour hyperactivité détrusorienne neurogène : résultats de l’enquête DETOX

[1]  P. Marque,et al.  Preliminary results of botulinum toxin A switch after first detrusor injection failure as a treatment of neurogenic detrusor overactivity , 2016, Neurourology and urodynamics.

[2]  A. Guinet-Lacoste,et al.  Ancienneté de la neurovessie et efficacité d’une première injection de toxine botulique intradétrusorienne , 2015 .

[3]  S. Han,et al.  Preoperative urodynamic factors predicting outcome of botulinum toxin-A intradetrusor injection in children with neurogenic detrusor overactivity. , 2014, Urology.

[4]  A. Nambiar,et al.  Chapter 4: Guidelines for the diagnosis and treatment of overactive bladder (OAB) and neurogenic detrusor overactivity (NDO) , 2014, Neurourology and urodynamics.

[5]  J. Cornu,et al.  Les médicaments de la vessie , 2013 .

[6]  G. Karsenty,et al.  Five years follow-up study and failures analysis of Botulinum toxin repeated injections to treat neurogenic detrusor overactivity. , 2012, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[7]  M. Brin,et al.  Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity. , 2012, The Journal of urology.

[8]  S. Biers,et al.  The past, present and future of augmentation cystoplasty , 2012, BJU international.

[9]  M. Brin,et al.  Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial. , 2011, European urology.

[10]  P. Dasgupta,et al.  Contemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA). , 2011, European urology.

[11]  J. Gajewski,et al.  Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: a randomized, double-blind trial. , 2011, The Journal of urology.

[12]  X. Gamé,et al.  Chapitre C-2 C - Traitement de l’hyperactivité détrusorienne neurologique : entérocystoplasties , 2007 .

[13]  L. Brundin,et al.  Efficacy and impact of botulinum toxin A on quality of life in patients with neurogenic detrusor overactivity , 2007, Scandinavian journal of urology and nephrology.

[14]  C. Heneghan,et al.  Levels of Evidence , 2006 .

[15]  M. Brin,et al.  Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. , 2005, The Journal of urology.

[16]  B. Schurch,et al.  Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. , 2000, The Journal of urology.